Shire ( SHPGY) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole was unchanged today. By the end of trading, Shire rose $1.56 (1.6%) to $98.61 on average volume. Throughout the day, 691,649 shares of Shire exchanged hands as compared to its average daily volume of 590,800 shares. The stock ranged in a price between $97.88-$99.26 after having opened the day at $99.09 as compared to the previous trading day's close of $97.05. Other companies within the Health Care sector that increased today were: Amarin Corporation ( AMRN), up 17.2%, Neptune Technologies & Bioressources ( NEPT), up 14%, Incyte ( INCY), up 13%, and Ampio Pharmaceuticals ( AMPE), up 12%. Shire plc, a specialty biopharmaceutical company, engages in the research and development, manufacture, sale, and distribution of pharmaceutical products. It operates in three segments: Specialty Pharmaceuticals, Human Genetic Therapies, and Regenerative Medicine. Shire has a market cap of $18.06 billion and is part of the drugs industry. The company has a P/E ratio of 21.3, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are down 6.6% year to date as of the close of trading on Wednesday. Currently there are nine analysts that rate Shire a buy, no analysts rate it a sell, and seven rate it a hold. TheStreet Ratings rates Shire as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.
- You can view the full Shire Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.